{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6qvO8LDA","lastupdate":"2024-09-25T00:00:00.000Z","update_date":"2024-09-25T00:00:00.000Z","lastModified":"Feb 25, 2025","active":1,"confidence_score":92,"confidence_score_reason":"markets, not claimed","urlname":"perflow-medical","minimal_profile":null,"status":"","fullstatus":"","acquired":1,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$ndj4mwGLV5ESE7oHqNyKALL8Pio3r79xSgRffLGC9KhqdVMPxEhmqh","name":"Perflow Medical","oneliner":"Medical Device to Control Neurovascular Disorders","registrar":"514414754","website":"https://perflow.com/","careerspage":"","founded_month":3,"founded_year":2010,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/PerflowM","youtube":"https://www.youtube.com/channel/UClqFH_62avplZfkGJvO_9Og","facebook":"https://www.facebook.com/perflowmedical","linkedin":"https://www.linkedin.com/company/18872166","instagram":""},"social":["https://www.youtube.com/channel/UClqFH_62avplZfkGJvO_9Og","https://www.linkedin.com/company/18872166","https://www.facebook.com/perflowmedical","https://twitter.com/PerflowM"],"flattenedsociallinks":"https://www.youtube.com/channel/UClqFH_62avplZfkGJvO_9Og|https://www.linkedin.com/company/18872166|https://www.facebook.com/perflowmedical|https://twitter.com/PerflowM","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":21,"patent":1,"raised":13600000,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":null,"about":"Perflow is focused on developing, manufacturing, and commercializing neurovascular interventional products designed to provide positive patient clinical results. The companys CEREBRAL NET technological platform has been used to create three neurovascular treatment devices used for thrombectomy, aneurysm neck bridging, and flow diversion. \r\n\r\nIn conjunction with improving existing device categories, Perflows technology enables the creation of new device categories upon which new endovascular treatment approaches can be developed for additional indications. \r\n\r\nThe companys Stream Dynamic Neuro-Thrombectomy Net and the Cascade Non-Occlusive Remodeling Net are CE marked. Perflow products are not available for sale in the United States.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97236544011","country":null,"address":{"israeli":[{"id":"6c35e8aa-0a41-4db1-87ca-4b591fd41cc9","city":"Netanya","type":null,"address":"HaTsoran Street 4, Netanya, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"ac5ef2ce-bfb6-4c0c-a332-8bf80fcb2c1d","city":null,"address":"China","country":"China","placeid":null},{"id":"b4ac9971-57e8-4930-9973-6822b12f9a9b","city":null,"address":"Belgium","country":"Belgium","placeid":null},{"id":"c18a7e5a-f9f3-4f8c-8a88-9c32ddf2d7b7","city":null,"address":"California, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"0321e305-1c70-4a36-9bdd-3cc784210ae6","date":"Jan 5, 2022","link":"https://en.globes.co.il/en/article-chinese-fund-buys-perflow-medical-for-100m-1001397403","source":"en.globes.co.il","visible":1,"analysis":{"tags":"acquisition","company":"Perflow Medical","layoffs":null,"summary":"Israeli medical device company Perflow Medical has been acquired by an unnamed Chinese private equity firm for approximately $100 million. Perflow Medical develops neurovascular treatments for hemorrhagic and ischemic strokes. The company was founded in 2014 and has raised $17 million to date. This is the second exit for CEO Danny Farin, who previously managed EON Surgical. Perflow Medicals innovative technology allows doctors to precisely control the diameter of the mesh and remove blood clots from the brains blood vessels. Their first device has received EU clearance but is awaiting FDA approval for the US market.","partners":null,"customers":null,"investors":"Unnamed Chinese private equity firm","confidence":9,"key_topics":["medical device","neurovascular treatments","acquisition","Chinese private equity firm","financial details"],"date_of_event":"January 5, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":"$100 million","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YtAPVXkd9cQpHaALjmJCZ8q4TqJqkxS1HI2ZQp9h0k1CIQ3YkzqyCl","news_summary":"Chinese fund buys Perflow Medical for $100m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"60bdeca0-19ec-46fa-b6fc-6bbc0e0eecbd","date":"Apr 29, 2021","link":"https://www.prnewswire.com/il/news-releases/perflow-medical-expands-product-portfolio-with-first-clinical-use-of-the-stream-tm-17-dynamic-neuro-thrombectomy-net-815416641.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["neurovascular treatments"],"company":"Perflow Medical","layoffs":null,"summary":"Perflow Medical has announced the successful clinical use of the Stream17 Dynamic Neuro-Thrombectomy Net, a device designed for neurovascular treatments. The device, built on Perflows proprietary CEREBRAL NET technology, expands the range of brain vessels that can be treated. The first clinical procedures were completed by Prof. Karlis Kupcs in Latvia. The company also offers the Cascade17 Dynamic Non-Occlusive Remodeling Net for coil embolization of intracranial aneurysms. Perflows products are commercially available in Europe but not yet cleared for use in the United States.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Stream17","CEREBRAL NET technology","neurovascular treatments","clinical use","product portfolio"],"date_of_event":"April 29, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"MchhozhhN3iZQ1DmzPn7AJUKokuXSDWyWmyKY4Ztt8VMqjb8ExD66y","news_summary":"Perflow Medical Expands Product Portfolio with First Clinical Use of the Stream™17 Dynamic Neuro-Thrombectomy Net","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"107f393c-788b-416b-897b-e5be00e2386e","date":"Mar 10, 2021","link":"https://www.prnewswire.com/il/news-releases/perflow-medical-announces-the-first-clinical-use-of-the-cascade-17-dynamic-non-occlusive-remodeling-net-301244869.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"neurovascular treatment","company":"Perflow Medical","layoffs":null,"summary":"Perflow Medical has launched the Cascade 17 Non-Occlusive Remodeling Net in the European market. The Cascade17 is a neurovascular device that optimizes non-occlusive support during coil embolization of intracranial aneurysms. It is based on Perflows proprietary CEREBRAL NET technology. The device enables continuous blood flow during cerebral aneurysm repair and coiling, potentially improving patient outcomes. Early clinical experience with the Cascade17 has been promising. Perflow Medical plans to launch more products, including the Stream17 Dynamic Neuro-Thrombectomy Net. The Cascade Net and Stream Net product families are available in Europe, but not yet approved for clinical use in the United States.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Cascade17","CEREBRAL NET technology","neurovascular devices","European market","patient outcomes"],"date_of_event":"March 10, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rvJz6iZqrtrl0p4zKLJdWBO7MxWIBIclkQdzpILg2ehvL5V5OK3GJR","news_summary":"Perflow Medical Announces the First Clinical Use of the Cascade™ 17 Dynamic Non-Occlusive Remodeling Net","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"08f04fc0-5660-46d4-9bdd-527a84925355","date":"Oct 21, 2019","link":"https://www.biospace.com/article/releases/perflow-medical-receives-ce-mark-approval-of-novel-cascade-agile/","source":"www.biospace.com","visible":1,"analysis":{"tags":"clinical data","company":"Perflow Medical","layoffs":null,"summary":"Perflow Medical has received CE Mark approval for the Cascade Agile Non-Occlusive Remodeling Net, expanding their product family for neurovascular treatment. The Cascade Agile provides better control for distal and tortuous vessel anatomy during coil embolization of intracranial aneurysms. Perflow Medical also published an article highlighting the clinical experience with the Cascade Net for the treatment of ruptured intercranial aneurysms. The companys focus on providing physicians with more intraoperative control and better information has been well received by the market. Perflow Medical plans to publish their clinical experience with the Stream and Cascade Net, fueling future commercial expansion. The Cascade product family and Stream Net are commercially available in Europe, but not approved for clinical use in the United States.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Cascade Net","neurovascular treatment","CE Mark approval","clinical experience","Cascade Agile"],"date_of_event":"October 21, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ebP0g9Rz5O4XJeIIvgE4rz2IKSpNTsIxciZvNRZMxCl9jMLDBjv1Er","news_summary":"Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile  BioSpace","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8ff03d47-0615-451f-af75-343f69a71af6","date":"Jan 10, 2019","link":"https://www.prnewswire.com/il/news-releases/perflow-medical-expands-ip-coverage-for-novel-stream-tm-dynamic-neuro-thrombectomy-net-device-and-cascade-tm-non-occlusive-remodeling-net-886613559.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"neuro-interventional devices","company":"Perflow Medical","layoffs":null,"summary":"Perflow Medical, an Israeli-based medtech company, has announced the issuance of four international patents that expand its global intellectual property (IP) coverage for its neuro-interventional devices. The companys growing portfolio now includes eight issued patents, with two new patents from the European Patent Office, one from the China National Intellectual Property Administration, and one from the Japanese Patent Office. Perflow Medicals CEREBRAL NET technology platform, which includes the Stream and Cascade devices, offers real-time control and improved device performance for the treatment of complex neurovascular disorders. The company currently has two commercial products available in Europe and is focused on expanding its global reach. Clinical experience with the Stream and Cascade devices will be presented at the ABC-WIN Seminar in January 2019.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["patents","neuro-interventional devices","IP coverage","commercial products","physician control"],"date_of_event":"2019-01-10","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pEWttxReqM2HUjW7YhbsTK0vzzZRA5eCs3ms9UMddWZOmm6bH7FFYo","news_summary":"Perflow Medical Expands IP Coverage for Novel Stream™ Dynamic Neuro-Thrombectomy Net Device and Cascade™ Non-Occlusive Remodeling Net","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7d19b35f-64a1-4aed-b4ed-7c3d3fa3a03f","date":"Jul 23, 2018","link":"https://www.prnewswire.com/news-releases/perflow-medical-announces-the-first-clinical-use-of-the-cascade-dynamic-non-occlusive-remodeling-net-801834874.html","source":"www.prnewswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"DgjDU18V7ge33WH95oKzh57x4EXJDEIo8ulWEw2fl2W0hLGAQSfkt6","news_summary":"Perflow Medical Announces the First Clinical Use of the Cascade™ Dynamic Non-Occlusive Remodeling Net","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"41ccade2-5820-45b9-b294-88a351132476","date":"Feb 15, 2018","link":"http://www.finsmes.com/2018/02/perflow-medical-closes-12m-financing-round.html","source":"www.finsmes.com","visible":1,"analysis":{"tags":"financing","company":"Perflow Medical","layoffs":null,"summary":"Perflow Medical, a medical device company based in Tel Aviv, Israel, has closed a $12 million financing round. The funds will be used to commercialize their first product, the Stream Net device, in Europe and other countries, as well as to submit a U.S. FDA 510(k) dossier and develop two new products. Perflow Medical develops innovative tools for neurovascular interventions and its patent-protected CEREBRAL NET™ Technology platform enables adjustable neurovascular treatments.","partners":null,"customers":null,"investors":"existing investors, two new international investors, unnamed strategic investor","confidence":9,"key_topics":["Perflow Medical","financing","Stream Net device","CEREBRAL NET™ Technology","neurovascular interventions"],"date_of_event":"15/02/2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$12 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"tiinABVfVch0WBw0IJlig7mwn9TTFoxfj7546YRPjPR9aWtSgX2WeY","news_summary":"Perflow Medical Closes $12M Financing Round - FinSMEs","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d99c7b7f-9492-4cab-b818-54566a17aadb","date":"Dec 7, 2016","link":"http://www.prnewswire.com/news-releases/perflow-medical-announces-issuance-of-patent-for-the-stream-dynamic-neuro-thrombectomy-net-to-improve-thrombus-removal-post-stroke-300373699.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"neurointerventional devices","company":"Perflow Medical","layoffs":null,"summary":"Perflow Medical has announced the issuance of a US patent for their Stream Dynamic Neuro-Thrombectomy Net, the first device to provide full dynamic wall apposition during the treatment of acute ischemic stroke. The device allows physicians to have full control of the radiopaque, braided net to make real-time adjustments based on intracranial vessel geometry. This technology aims to improve patient outcomes by leveraging the physicians expertise and experience. The Stream Net is approved in Europe for the endovascular treatment of acute ischemic stroke.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["neurointerventional devices","stroke treatment","Stream Net","physician control","patient outcomes"],"date_of_event":"December 7, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"dDIHey0NR5hjlnuesE5Wft2iGnNbgoYt1tWIRMcuNTa0LD3xwBj0Uq","news_summary":"Perflow Medical Announces Issuance of Patent for The Stream™ Dynamic Neuro-Thrombectomy Net to Improve Thrombus Removal Post-Stroke","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":8,"techcommunityinvolvement":null,"mediagallery":[{"id":"d51b4674-a267-4c91-83f3-697ecb5f8340","timestamp":"2020-11-19 09:50:08.000000","resources_type":2,"resources_title":"","resources_file_name":"BPOeT766bmg","alt":"","imageurl":"https://img.youtube.com/vi/BPOeT766bmg/0.jpg","url":"http://youtu.be/BPOeT766bmg"},{"id":"14c22528-f3b4-40ee-bb75-f9e4093ff910","timestamp":"2018-12-25 08:37:34.000000","resources_type":2,"resources_title":"Trailer","resources_file_name":"tLdHzm_D-OA","alt":"Trailer logo","imageurl":"https://img.youtube.com/vi/tLdHzm_D-OA/0.jpg","url":"http://youtu.be/tLdHzm_D-OA"}],"tags":["neurovascular","stroke","medical-devices","hospitals","surgery","real-time","doctors","healthcare-providers","treatments","surgery-tools"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":[{"date":"2010-03-01","name":"Excellent visibility under fluoroscopy","tags":["surgery"],"category":"Medical Devices","tto_logo":"/image_cloud/t3_tto_logo_f5fde2b3-6016-11e8-abf1-41fdcbb0dda6","university_logo":"/image_cloud/t3_institution_logo_f5fde2b3-6016-11e8-abf1-41fdcbb0dda6"}],"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["Stream","Cascade"],"geomarkets":["Europe"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":5,"lastfunding":"$12M","totalrounds":2,"fundingstage":"Mature","totalfunding":"$13.6M","publicinvestors":5,"lastpublicfunding":12000000,"totalpublicrounds":2,"totalpublicfunding":13600000},"team":[{"name":"Danny Farin","email":"DannyF@perflow.com","phone":"0548152829","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgNGHqcEIDA","bounced":false,"claimed":0,"founder":1,"urlname":"danny-farin-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAvtrOygkM","position":"Co-founder & CEO","last_name":"Farin","claimtoken":"0a440f4857f4280850fb1d5ac382f0d4cd7787f999be0f4cbbf66be101a21e23","first_name":"Danny","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/danny-farin-aa08039/","unsubscribed":false,"is_activeuser":0,"additionalemail":"danny.farin@perflowmedical.com","claimedemaildate":"2022-01-05 09:21:03.000000","initials":"DF","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Eyal Orion, MD, MBA","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkIT0rvALDA","bounced":false,"claimed":0,"founder":1,"urlname":"eyal-orion-md-mba","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQ-MjoggsM","position":"Co-founder","last_name":"Orion, MD, MBA","claimtoken":"a6e1380b292594849fcdc16dceceeb4fcfade7a1f5e2b609393b35b75f44827c","first_name":"Eyal","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/eyal-orion-md-mba-952a71b7/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"EO","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Avi  Rappaport","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkKiWwPELDA","bounced":false,"claimed":0,"founder":1,"urlname":"avi-rappaport","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQhPSX4QkM","position":"Co-founder","last_name":"Rappaport","claimtoken":"19e075c893ee745842df362cc8cf28fa76ba179c0a80504a14d7deb86a4c11c6","first_name":"Avi ","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"AR","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Gilad  Cibulski","email":"giladc@perflow.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4KbLv9UKDA","bounced":false,"claimed":0,"founder":1,"urlname":"gilad-cibulski-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg5tiouwkM","position":"Co-founder & VP R&D","last_name":"Cibulski","claimtoken":"be0aba6376e70b9b61974efc7f597f294ae791d31e4d76634cf057ae93c2b8d1","first_name":"Gilad ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/gilad-cibulski-62938a13/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-01-05 09:21:04.000000","initials":"GC","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Guy  Neuberger","email":"guyn@perflow.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkLjYjIAJDA","bounced":false,"claimed":0,"founder":0,"urlname":"guy-neuberger","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQ-IiguQgM","position":"COO","last_name":"Neuberger","claimtoken":"1c309be12c4f0a3b143f3da951d5af1ad15e01162b09cf001a5e50a7a07dad47","first_name":"Guy ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/guy-neuberger-0859134/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-01-05 09:21:08.000000","initials":"GN","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Mark  Vekemans","email":"markv@perflow.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkPiiuIELDA","bounced":false,"claimed":0,"founder":0,"urlname":"mark-vekemans","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQhIzshQoM","position":"Director of Sales and Marketing","last_name":" Vekemans","claimtoken":"78485b5f6340ed4f29e1af9d7905ba4e1a26af4f37802a94de3e79f65886b75e","first_name":"Mark","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/mark-vekemans-5290242/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-01-05 09:21:06.000000","initials":"M ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7UwIEIDA","fullname":"Aviv Alper"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-02-17T00:00:00.000Z","crunchbaseid":"perflow-medical","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":null,"creator_email":null,"createdate":"2014-11-30T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Aviv Alper","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODcpq6zCgw","date":"Jul 2018","amount":"Undisclosed","source":"https://www.prnewswire.com/news-releases/perflow-medical-announces-the-first-clinical-use-of-the-cascade-dynamic-non-occlusive-remodeling-net-801834874.html","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"TailorMed","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODc5vWQCgw","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/tailormed-1","acquiredcompany_mna_logokey":"$Fo9WUpKiLwRV3TjCpQ4uQ2UHb9INWiNa8u3EsbcEex9NslFCC6JGBz","acquiredcompany_mna_urlname":"/company_page/tailormed-1","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$Fo9WUpKiLwRV3TjCpQ4uQ2UHb9INWiNa8u3EsbcEex9NslFCC6JGBz","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmsfpCAw","date":"Feb 2018","amount":"$12M","source":"https://en.globes.co.il/en/article-neurovascular-device-co-perflow-medical-raises-12m-1001224293 + silent round","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5fa90f18-3cdc-4858-8c04-5d773f56c718","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"RAD BioMed","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/radbiomed","logokey":"$8Q5Rwt22LKpRes13ZNTxXwFNiOfEKKujTG6u7PIRBDQr1KJWlllXfv","tagline":null,"urlname":"/investor_page/radbiomed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKOh2oAKDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"t5UglEJyV0K77aI8razxHlKnnly0KCQMgGXmOw22DfppUbxD8irobF","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8Q5Rwt22LKpRes13ZNTxXwFNiOfEKKujTG6u7PIRBDQr1KJWlllXfv","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":12000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"HmsAAEs9uTXwik2GyQpr0TPm6J7YHct84tCPfUzAkil5K49Hw9qxjn","date":"Apr 2014","amount":"$1.6M","source":"https://en.globes.co.il/en/article-5-former-rad-biomed-portfolio-cos-raise-7m-1000930112","eventtype":"FundingRoundEvent","investment":[{"name":"Yehuda Zisapel (Late)","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/yehuda-zisapel-late","logokey":"$prsLqopz8iSzcD7p6TNH3y8QKZHax5QiJP0qCdeJPbivJOKxaaJP4l","tagline":null,"urlname":"/investor_page/yehuda-zisapel-late","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKCh6OIIDA","fundingtype":"Angel","leadpartner":null,"investmentid":"ItsbnQCBk3xWScfqwzbXqKQFCmVBFZOF5XVxdpNyY1SnsZT2oMY9OK","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$prsLqopz8iSzcD7p6TNH3y8QKZHax5QiJP0qCdeJPbivJOKxaaJP4l","leadcaption":"","followupcaption":""},{"name":"Shanghai Creation Investment Management Co","type":"Investor","amount":null,"hidden":false,"country":"China","fullurl":"/investor_page/shanghai-creation-investment-management-co","logokey":null,"tagline":"","urlname":"/investor_page/shanghai-creation-investment-management-co","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEv5PaCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"hAx7cZQGtkB7voWZaJ3WgDeb24hiIlMjKh10oCkzVdQjzzTDw6FmK6","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Pix Vine Capital","type":"Investor","amount":null,"hidden":false,"country":"Singapore","fullurl":"/investor_page/pix-vine-capital","logokey":"$yS4CvF4Ymgk830cXl4tUixJibuI1LKGABP047LoTXA8WQc8GnhvPI7","tagline":null,"urlname":"/investor_page/pix-vine-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7V_Z8LDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"nFNHLYkPZmAfMDI0AbCYbnloXpVsXRY1jYjmwcVvGcrPB3uLRwdDBm","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$yS4CvF4Ymgk830cXl4tUixJibuI1LKGABP047LoTXA8WQc8GnhvPI7","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"3/2010","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Perflow Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$ndj4mwGLV5ESE7oHqNyKALL8Pio3r79xSgRffLGC9KhqdVMPxEhmqh","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$ndj4mwGLV5ESE7oHqNyKALL8Pio3r79xSgRffLGC9KhqdVMPxEhmqh","seoabout":"Perflow is focused on developing, manufacturing, and commercializing neurovascular interventional products designed to provide positive patient clinical re...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":6,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":[],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmsfpCAw","date":"Feb 2018","amount":"$12M","source":"https://en.globes.co.il/en/article-neurovascular-device-co-perflow-medical-raises-12m-1001224293 + silent round","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5fa90f18-3cdc-4858-8c04-5d773f56c718","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"RAD BioMed","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/radbiomed","logokey":"$8Q5Rwt22LKpRes13ZNTxXwFNiOfEKKujTG6u7PIRBDQr1KJWlllXfv","tagline":null,"urlname":"/investor_page/radbiomed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKOh2oAKDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"t5UglEJyV0K77aI8razxHlKnnly0KCQMgGXmOw22DfppUbxD8irobF","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8Q5Rwt22LKpRes13ZNTxXwFNiOfEKKujTG6u7PIRBDQr1KJWlllXfv","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":12000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"HmsAAEs9uTXwik2GyQpr0TPm6J7YHct84tCPfUzAkil5K49Hw9qxjn","date":"Apr 2014","amount":"$1.6M","source":"https://en.globes.co.il/en/article-5-former-rad-biomed-portfolio-cos-raise-7m-1000930112","eventtype":"FundingRoundEvent","investment":[{"name":"Yehuda Zisapel (Late)","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/yehuda-zisapel-late","logokey":"$prsLqopz8iSzcD7p6TNH3y8QKZHax5QiJP0qCdeJPbivJOKxaaJP4l","tagline":null,"urlname":"/investor_page/yehuda-zisapel-late","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKCh6OIIDA","fundingtype":"Angel","leadpartner":null,"investmentid":"ItsbnQCBk3xWScfqwzbXqKQFCmVBFZOF5XVxdpNyY1SnsZT2oMY9OK","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$prsLqopz8iSzcD7p6TNH3y8QKZHax5QiJP0qCdeJPbivJOKxaaJP4l","leadcaption":"","followupcaption":""},{"name":"Shanghai Creation Investment Management Co","type":"Investor","amount":null,"hidden":false,"country":"China","fullurl":"/investor_page/shanghai-creation-investment-management-co","logokey":null,"tagline":"","urlname":"/investor_page/shanghai-creation-investment-management-co","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEv5PaCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"hAx7cZQGtkB7voWZaJ3WgDeb24hiIlMjKh10oCkzVdQjzzTDw6FmK6","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Pix Vine Capital","type":"Investor","amount":null,"hidden":false,"country":"Singapore","fullurl":"/investor_page/pix-vine-capital","logokey":"$yS4CvF4Ymgk830cXl4tUixJibuI1LKGABP047LoTXA8WQc8GnhvPI7","tagline":null,"urlname":"/investor_page/pix-vine-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7V_Z8LDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"nFNHLYkPZmAfMDI0AbCYbnloXpVsXRY1jYjmwcVvGcrPB3uLRwdDBm","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$yS4CvF4Ymgk830cXl4tUixJibuI1LKGABP047LoTXA8WQc8GnhvPI7","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODcpq6zCgw","date":"Jul 2018","amount":"Undisclosed","source":"https://www.prnewswire.com/news-releases/perflow-medical-announces-the-first-clinical-use-of-the-cascade-dynamic-non-occlusive-remodeling-net-801834874.html","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"TailorMed","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODc5vWQCgw","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/tailormed-1","acquiredcompany_mna_logokey":"$Fo9WUpKiLwRV3TjCpQ4uQ2UHb9INWiNa8u3EsbcEex9NslFCC6JGBz","acquiredcompany_mna_urlname":"/company_page/tailormed-1","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$Fo9WUpKiLwRV3TjCpQ4uQ2UHb9INWiNa8u3EsbcEex9NslFCC6JGBz","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"others":[]}}